Unknown

Dataset Information

0

Vonoprazan–minocycline dual therapy as a first-line treatment of Helicobacter pylori infection compared with empirical bismuth-containing quadruple therapy

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC12374092 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Minocycline/Amoxicillin-Based Bismuth Quadruple Therapy for <i>Helicobacter pylori</i> Eradication: A Pilot Study.
| S-EPMC10972041 | biostudies-literature
Unknown Evaluation of safety and pharmacokinetics of bismuth-containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication.
| S-EPMC9291775 | biostudies-literature
Unknown Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for <i>Helicobacter pylori</i> infection.
| S-EPMC7524369 | biostudies-literature
Unknown Effect of Saccharomyces boulardii supplementation to bismuth quadruple therapy on Helicobacter pylori eradication.
| S-EPMC12008914 | biostudies-literature
Unknown Efficacy and safety of vonoprazan-amoxicillin dual therapy versus bismuth-containing quadruple therapy for patients with &lt;i&gt;Helicobacter pylori&lt;/i&gt; infection: a meta-analysis.
| S-EPMC11962034 | biostudies-literature
Unknown Ten-day bismuth-containing quadruple therapy versus 7-day proton pump inhibitor-clarithromycin containing triple therapy as first-line empirical therapy for the Helicobacter pylori infection in Korea: a randomized open-label trial.
| S-EPMC7923489 | biostudies-literature
Unknown Vonoprazan-based quadruple therapy is non-inferior to esomeprazole-based quadruple therapy for Helicobacter pylori eradication: A multicenter, double-blind, randomized, phase 3 study.
| S-EPMC12634238 | biostudies-literature
Unknown Modified quadruple therapy versus bismuth-containing quadruple therapy in first-line treatment of Helicobacter pylori infection in Korea; rationale and design of an open-label, multicenter, randomized controlled trial.
| S-EPMC6257664 | biostudies-literature
Unknown The efficacy and safety of vonoprazan in quadruple therapy for <i>Helicobacter pylori</i> eradication: a comparative study.
| S-EPMC11018536 | biostudies-literature
Unknown Susceptibility-guided bismuth quadruple therapies for resistant <i>Helicobacter pylori</i> infections.
| S-EPMC8985787 | biostudies-literature